Old psychiatric drug repurposed in fight against deadly brain cancer
NCT ID NCT05190315
Summary
This small, early-stage study tested whether adding a low dose of an old psychiatric drug called chlorpromazine to the standard treatment for a fast-growing brain cancer (glioblastoma) is safe. Ten adults with newly diagnosed cancer received the drug combination alongside radiation and chemotherapy. The main goal was to find a safe dose and check for side effects, while also seeing if it might help delay the cancer's return.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA MULTIFORME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Iowa Hospitals & Clinics
Iowa City, Iowa, 52242, United States
Conditions
Explore the condition pages connected to this study.